JANE-2

The JANE-2 project, part of the EU's unified action, aims to develop seven new, mutually integrated Expertise Networks accessible to both patients and healthcare professionals. This network is expected to enhance and improve the quality of life both in the fight against cancer and after it has been overcome.

The Expertise Networks will cover the following areas:

1. Complex and poor prognosis cancer cases;
2. Palliative care;
3. Cancer recovery;
4. Personalized primary/secondary prevention;
5. Omics technologies;
6. High-tech medical resources;
7. Cancer incidence among adolescents and young adults.

It is anticipated that the newly established Expertise Networks will strengthen the European cancer community, providing various services:

a) Development or support of clinical practice guidelines and/or general recommendations for medical professionals, patients, and the public;
b) Raising public awareness and advocacy/policy formation;
c) Creating organizational models for healthcare;
d) Developing educational initiatives/tools for medical professionals and patients;
e) Implementing research promotion activities;
f) Establishing quality criteria for accreditation/approval mechanisms;
g) Engaging patients and the public.

Project implementation period: from 11/01/2024 to 11/01/2028.

Project ID No.: ID No. 101183265; LU reg. No. ZD2024/21792

Leading partner in Latvia: Paula Stradiņš Clinical University Hospital

Project partners in Latvia: Riga Eastern Clinical University Hospital, Riga Stradiņš University, Institute of Clinical and Preventive Medicine, University of Latvia

Total project funding: 50,717,563.17 euros

Total funding for UL: 321,654.84 euros

Of which:

International funding - 257,323.87 euros,

National funding - 64,330.97 euros.

Project partners: 121 partners from 29 different EU countries.

The project "Establishment of a Cancer Expertise Network" has received funding from the European Union (European Health and Digital Executive Agency (HaDEA)) under the EU4Health program according to grant agreement No. 101183265.